Oslo, December 12, 2024 - Observe Medical ("the Company" or "Observe Medical") announces that the order intake of UnoMeter™ Safeti™ Plus has now reached 18 countries and brings the current order intake beyond NOK 5 million only 4 weeks after the product was launched.  The Company expects that this number will continue to increase in the coming weeks. First deliveries are expected before Christmas and will pick up speed in January and onwards.

Jørgen Mann, CEO of Observe Medical, commented, "We are seeing a continued positive development in the order intake on our UnoMeter™ portfolio, and particularly on UnoMeter™ Safeti™ Plus. With the first deliveries starting shortly we expect that we can continue taking back the historic market share of the UnoMeter™ family and thereby securing a strong distribution platform and financial resources to support our ambition to become market leader within urine output measurement".

For further information, please contact:

Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.